摘要:
A compound of formula 1 wherein: A is a group selected from X− is an anion with a single negative charge; R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen; and R3, R4, R5, R6, R7, and R8 are each independently hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, CF3, CN, NO2, or halogen, with the proviso that at least one of the groups R3, R4, R5, R6, R7, and R8 is not hydrogen, processes for preparing these compounds, pharmaceutical compositions containing these compounds, and their use as pharmaceutical compositions.
摘要:
Fluorenecarboxylic acid esters of general formula 1 wherein X− and the groups A, R, R1, R2, R3, R3′, R4, and R4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.
摘要:
Xanthenecarboxylates of formula 1 wherein: A is a group selected from X− is an anion with a single negative charge; R is hydroxy, methyl, hydroxymethyl, ethyl, —CF3, —CHF2, or fluorine; R1 and R2, which are identical or different, are each C1-C5-alkyl which is optionally substituted by C3-C6-cycloalkyl, hydroxy, or halogen, or R1 and R2 together denote a —C3-C5-alkylene-bridge; and R3, R4, R3′, and R4′, which are identical or different, are each hydrogen, —C1-C4-alkyl, —C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen, or a physiologically acceptable salt thereof, processes for preparing, them and their use in pharmaceutical compositions.
摘要:
A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X− is an anion with a single negative charge; and (b) a steroid 2, processes for preparing such pharmaceutical composition, and their use in the treatment of respiratory complaints.
摘要:
The present invention relates to new anticholinergics of general formula 1 wherein A, X−, and the groups R1, R2, R3, R4, R5, R6 and R7 may have the meanings given in the claims and in the specification, processes for preparing them and their use as pharmaceutical compositions.
摘要:
The invention relates to a microscope having an optics system which represents an object on an image sensor and a screen that shows the image data provided by the image sensor and which is the only output medium for visually observing the object, wherein the representation capability of the optics system and the resolution (A) of the image sensor complies with the following correlation: F×N/M=0.5 A, wherein F indicates a factor, N indicates the numerical aperture of the optics systems, M is the magnification factor and A indicates the resolution of the image sensor in pixels per millimeter.
摘要翻译:本发明涉及具有表示图像传感器上的物体的光学系统和显示由图像传感器提供的图像数据并且是用于目视观察物体的唯一输出介质的屏幕的显微镜,其中, 光学系统和图像传感器的分辨率(A)符合以下相关:FxN / M = 0.5A,其中F表示因子,N表示光学系统的数值孔径,M表示放大系数,A表示 图像传感器的分辨率为每毫米像素。
摘要:
Fluorenecarboxylic acid esters of general formula 1 wherein X− and the groups A, R, R1, R2, R3, R3′, R4, and R4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof a medicaments.
摘要:
Fluorenecarboxylic acid esters of general formula 1 wherein X− and the groups A, R, R1, R2, R3, R3′, R4, and R4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.